NASDAQ:IKNA
Ikena Oncology, Inc.
- Stock
Share Trends
Recent Transactions
Reporter | Filed at | Change (shares) |
---|---|---|
Orbimed Advisors Llc Director Common Stock | 2023-09-14 | 153.12K 7.30% |
Bonita David P Director Common Stock | 2023-09-14 | 153.12K 7.30% |
Orbimed Advisors Llc Director Common Stock | 2022-06-24 | 118.61K 5.99% |
Bonita David P Director Common Stock | 2022-06-24 | 118.61K 5.99% |
Tessier Maude Chief Business Officer Common Stock | 2022-01-20 | 71.79K 249.33% |
Largest Transactions
Reporter | Filed at | Change (shares) |
---|---|---|
Stampacchia Otello Director Common Stock | 2021-04-01 | 2.25M 100% |
Formela Jean Francois Director Common Stock | 2021-04-01 | 749.63K 100% |
Atlas Venture Fund X, L.P. Director Common Stock | 2021-04-01 | 749.63K 100% |
Formela Jean Francois Director Common Stock | 2021-12-14 | 492.30K 65.67% |
Atlas Venture Fund Xi, L.P. Director Common Stock | 2021-12-14 | 492.30K 65.67% |
Transaction Log
Filing Date | Transaction Date | Reporter | Title | Post Shares | Quantity | T | Stock Class | USD |
---|---|---|---|---|---|---|---|---|
2023-09-14 | 2023-08-04 | Bonita David P | Director | 2.25M | 153.12K | A | Common Stock | 0 |
2023-09-14 | 2023-08-04 | Orbimed Advisors Llc | Director | 2.25M | 153.12K | A | Common Stock | 0 |
2023-09-14 | 2023-08-04 | Orbimed Advisors Llc | Director | 2.25M | 153.12K | A | Common Stock | 0 |
2023-09-14 | 2023-08-04 | Orbimed Advisors Llc | Director | 2.25M | 153.12K | A | Common Stock | 0 |
2022-06-24 | 2022-06-22 | Bonita David P | Director | 1.91M | 66.81K | P | Common Stock | -237.16K |
2022-06-24 | 2022-06-24 | Bonita David P | Director | 2.00M | 65.97K | P | Common Stock | -288.27K |
2022-06-24 | 2022-06-24 | Bonita David P | Director | 2.10M | 96.03K | P | Common Stock | -515.71K |
2022-06-24 | 2022-06-22 | Orbimed Advisors Llc | Director | 1.91M | 66.81K | P | Common Stock | -237.16K |
2022-06-24 | 2022-06-24 | Orbimed Advisors Llc | Director | 2.00M | 65.97K | P | Common Stock | -288.27K |
2022-06-24 | 2022-06-23 | Orbimed Advisors Llc | Director | 1.94M | 23.42K | P | Common Stock | -86.88K |
2022-06-24 | 2022-06-22 | Orbimed Advisors Llc | Director | 1.91M | 66.81K | P | Common Stock | -237.16K |
2022-06-24 | 2022-06-24 | Orbimed Advisors Llc | Director | 2.10M | 96.03K | P | Common Stock | -515.71K |
2022-06-24 | 2022-06-24 | Orbimed Advisors Llc | Director | 2.00M | 65.97K | P | Common Stock | -288.27K |
2022-06-24 | 2022-06-23 | Orbimed Advisors Llc | Director | 1.94M | 23.42K | P | Common Stock | -86.88K |
2022-06-24 | 2022-06-23 | Bonita David P | Director | 1.94M | 23.42K | P | Common Stock | -86.88K |
2022-06-24 | 2022-06-22 | Orbimed Advisors Llc | Director | 1.91M | 66.81K | P | Common Stock | -237.16K |
2022-06-24 | 2022-06-23 | Orbimed Advisors Llc | Director | 1.94M | 23.42K | P | Common Stock | -86.88K |
2022-06-24 | 2022-06-24 | Orbimed Advisors Llc | Director | 2.00M | 65.97K | P | Common Stock | -288.27K |
2022-06-24 | 2022-06-24 | Orbimed Advisors Llc | Director | 2.10M | 96.03K | P | Common Stock | -515.71K |
2022-06-24 | 2022-06-24 | Orbimed Advisors Llc | Director | 2.10M | 96.03K | P | Common Stock | -515.71K |
2022-01-20 | 2022-01-18 | Tessier Maude | Chief Business Officer | 67.71K | 38.91K | M | Common Stock | 114.41K |
2022-01-20 | 2022-01-18 | Tessier Maude | Chief Business Officer | 100.58K | 8.27K | M | Common Stock | 37.28K |
2022-01-20 | 2022-01-18 | Tessier Maude | Chief Business Officer | 92.31K | 24.61K | M | Common Stock | 102.11K |
2022-01-12 | 2022-01-10 | Zhang Xiaoyan Michelle | Chief Scientific Officer | 44.51K | 36 | M | Common Stock | 77.26 |
2022-01-12 | 2022-01-10 | Zhang Xiaoyan Michelle | Chief Scientific Officer | 44.48K | 36 | S | Common Stock | -432 |
2022-01-12 | 2022-01-11 | Zhang Xiaoyan Michelle | Chief Scientific Officer | 45.44K | 964 | M | Common Stock | 2.07K |
2022-01-12 | 2022-01-11 | Zhang Xiaoyan Michelle | Chief Scientific Officer | 44.48K | 964 | S | Common Stock | -11.57K |
2021-12-14 | 2021-12-13 | Atlas Venture Fund Xi, L.P. | Director | 1.25M | 8.33K | S | Common Stock | -121.95K |
2021-12-14 | 2021-03-30 | Formela Jean Francois | Director | 874.63K | 125K | P | Common Stock | 2M |
2021-12-14 | 2021-12-10 | Formela Jean Francois | Director | 1.26M | 11.99K | S | Common Stock | -180.19K |
2021-12-14 | 2021-12-13 | Formela Jean Francois | Director | 1.25M | 8.33K | S | Common Stock | -121.95K |
2021-12-14 | 2021-12-14 | Formela Jean Francois | Director | 1.24M | 5.96K | S | Common Stock | -83.43K |
2021-12-14 | 2021-03-30 | Atlas Venture Fund Xi, L.P. | Director | 874.63K | 125K | P | Common Stock | 2M |
2021-12-14 | 2021-12-10 | Atlas Venture Fund Xi, L.P. | Director | 1.26M | 11.99K | S | Common Stock | -180.19K |
2021-12-14 | 2021-12-13 | Atlas Venture Fund Xi, L.P. | Director | 1.25M | 8.33K | S | Common Stock | -121.95K |
2021-12-14 | 2021-12-14 | Atlas Venture Fund Xi, L.P. | Director | 1.24M | 5.96K | S | Common Stock | -83.43K |
2021-12-14 | 2021-03-30 | Atlas Venture Fund Xi, L.P. | Director | 874.63K | 125K | P | Common Stock | 2M |
2021-12-14 | 2021-12-10 | Atlas Venture Fund Xi, L.P. | Director | 1.26M | 11.99K | S | Common Stock | -180.19K |
2021-12-14 | 2021-12-13 | Atlas Venture Fund Xi, L.P. | Director | 1.25M | 8.33K | S | Common Stock | -121.95K |
2021-12-14 | 2021-12-14 | Atlas Venture Fund Xi, L.P. | Director | 1.24M | 5.96K | S | Common Stock | -83.43K |
2021-12-14 | 2021-03-30 | Atlas Venture Fund Xi, L.P. | Director | 874.63K | 125K | P | Common Stock | 2M |
2021-12-14 | 2021-12-10 | Atlas Venture Fund Xi, L.P. | Director | 1.26M | 11.99K | S | Common Stock | -180.19K |
2021-12-14 | 2021-12-13 | Atlas Venture Fund Xi, L.P. | Director | 1.25M | 8.33K | S | Common Stock | -121.95K |
2021-12-14 | 2021-12-14 | Atlas Venture Fund Xi, L.P. | Director | 1.24M | 5.96K | S | Common Stock | -83.43K |
2021-12-14 | 2021-03-30 | Atlas Venture Fund Xi, L.P. | Director | 874.63K | 125K | P | Common Stock | 2M |
2021-12-14 | 2021-12-10 | Atlas Venture Fund Xi, L.P. | Director | 1.26M | 11.99K | S | Common Stock | -180.19K |
2021-12-14 | 2021-12-13 | Atlas Venture Fund Xi, L.P. | Director | 1.25M | 8.33K | S | Common Stock | -121.95K |
2021-12-14 | 2021-12-14 | Atlas Venture Fund Xi, L.P. | Director | 1.24M | 5.96K | S | Common Stock | -83.43K |
2021-12-14 | 2021-03-30 | Atlas Venture Fund Xi, L.P. | Director | 874.63K | 125K | P | Common Stock | 2M |
2021-12-14 | 2021-12-10 | Atlas Venture Fund Xi, L.P. | Director | 1.26M | 11.99K | S | Common Stock | -180.19K |
2021-12-14 | 2021-12-14 | Atlas Venture Fund Xi, L.P. | Director | 1.24M | 5.96K | S | Common Stock | -83.43K |
2021-12-14 | 2021-03-30 | Atlas Venture Fund Xi, L.P. | Director | 874.63K | 125K | P | Common Stock | 2M |
2021-12-14 | 2021-12-10 | Atlas Venture Fund Xi, L.P. | Director | 1.26M | 11.99K | S | Common Stock | -180.19K |
2021-12-14 | 2021-12-13 | Atlas Venture Fund Xi, L.P. | Director | 1.25M | 8.33K | S | Common Stock | -121.95K |
2021-12-14 | 2021-12-14 | Atlas Venture Fund Xi, L.P. | Director | 1.24M | 5.96K | S | Common Stock | -83.43K |
2021-12-14 | 2021-12-10 | Zhang Xiaoyan Michelle | Chief Scientific Officer | 45.48K | 1K | M | Common Stock | 2.15K |
2021-12-14 | 2021-12-10 | Zhang Xiaoyan Michelle | Chief Scientific Officer | 44.48K | 1K | S | Common Stock | -14.76K |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 749.63K | 749.63K | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 2.90M | 2.90M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 1.27M | 1.10M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 749.63K | 749.63K | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 1.82M | 1.82M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 1.82M | 1.82M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 68.98K | 68.98K | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 2.19M | 375K | P | Common Stock | 6M |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 2.90M | 2.90M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 1.27M | 1.10M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 749.63K | 749.63K | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 117.38K | 48.40K | P | Common Stock | 774.40K |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 5.08M | 5.08M | C | Non-Voting Common Stock | 0 |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 130.92K | 130.92K | C | Non-Voting Common Stock | 0 |
2021-04-01 | 2021-03-30 | Bonita David P | Director | 68.98K | 68.98K | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 2.90M | 2.90M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 1.27M | 1.10M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 749.63K | 749.63K | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Bonita David P | Director | 1.82M | 1.82M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Stampacchia Otello | Director | 2.25M | 450K | A | Common Stock | 7.20M |
2021-04-01 | 2021-03-30 | Stampacchia Otello | Director | 1.80M | 1.80M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 130.92K | 130.92K | C | Non-Voting Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 2.90M | 2.90M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 1.27M | 1.10M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 749.63K | 749.63K | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 5.08M | 5.08M | C | Non-Voting Common Stock | 0 |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 117.38K | 48.40K | P | Common Stock | 774.40K |
2021-04-01 | 2021-03-30 | Formela Jean Francois | Director | 2.90M | 2.90M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 2.19M | 375K | P | Common Stock | 6M |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 2.90M | 2.90M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 1.27M | 1.10M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 1.27M | 1.10M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 749.63K | 749.63K | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 1.82M | 1.82M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 68.98K | 68.98K | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 2.19M | 375K | P | Common Stock | 6M |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 117.38K | 48.40K | P | Common Stock | 774.40K |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 5.08M | 5.08M | C | Non-Voting Common Stock | 0 |
2021-04-01 | 2021-03-30 | Orbimed Advisors Llc | Director | 130.92K | 130.92K | C | Non-Voting Common Stock | 0 |
2021-04-01 | 2021-03-30 | Atlas Venture Fund X, L.P. | Director | 2.90M | 2.90M | C | Common Stock | 0 |
2021-04-01 | 2021-03-30 | Bonita David P | Director | 130.92K | 130.92K | C | Non-Voting Common Stock | 0 |
2021-04-01 | 2021-03-30 | Bonita David P | Director | 5.08M | 5.08M | C | Non-Voting Common Stock | 0 |
2021-04-01 | 2021-03-30 | Bonita David P | Director | 117.38K | 48.40K | P | Common Stock | 774.40K |